Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

被引：35
|
作者：
Meng, Lei [1 ,2 ]
Li, Xin-Yu [1 ,2 ]
Shen, Liang [1 ,2 ]
Ji, Hong-Fang [1 ,2 ]
机构：
[1] Shandong Univ Technol, Inst Biomed Res, Zibo, Shandong, Peoples R China
[2] Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Sch Life Sci, Zibo Key Lab New Drug Dev Neurodegenerat Dis, Zibo, Shandong, Peoples R China
来源：
TRENDS IN MOLECULAR MEDICINE | 2020年 / 26卷 / 06期
关键词：
AMYLOID-BETA-PROTEIN; GAMMA AGONIST PIOGLITAZONE; MILD COGNITIVE IMPAIRMENT; MODULATING TAU HYPERPHOSPHORYLATION; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; MOUSE MODEL; MEMORY IMPAIRMENT; INTRANASAL INSULIN; RECEPTOR AGONIST; PPAR-GAMMA;
D O I：
10.1016/j.molmed.2020.02.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) represent two major health burdens with steadily increasing prevalence and accumulating evidence indicates a close relationship between the two disorders. In view of their similar pathogenesis, the potential of T2DM drugs for the treatment of AD has attracted considerable attention in recent years, with inspiring outcomes. Here, we provide a comprehensive overview of the effects of a total of 14 individual drugs (among which are seven T2DM drug types) against AD. Further, we discuss the potential action mechanisms of these T2DM drugs against AD. We argue that these findings may open novel avenues for AD drug discovery, drug target identification, and cotreatment of the two disorders.
引用
下载
收藏
页码：597 / 614
页数：18
相关论文
共 50 条
  • [1] Alzheimer's disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities
    Bednarz, Krzysztof
    Siuda, Joanna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2021, 55 (05) : 418 - 428
  • [2] Type 2 diabetes mellitus and Alzheimer's disease
    Barbagallo, Mario
    Dominguez, Ligia J.
    WORLD JOURNAL OF DIABETES, 2014, 5 (06): : 889 - 893
  • [3] Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
    Abd A. Tahrani
    Anthony H. Barnett
    Clifford J. Bailey
    Nature Reviews Endocrinology, 2016, 12 : 566 - 592
  • [4] Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
    Tahrani, Abd A.
    Barnett, Anthony H.
    Bailey, Clifford J.
    NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (10) : 566 - 592
  • [5] Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
    Rasool, Mahmood
    Malik, Arif
    Qazi, Aamer M.
    Sheikh, Ishfaq A.
    Manan, Abdul
    Shaheen, Sumaira
    Qazi, Mahmood H.
    Chaudhary, Adeel G.
    Abuzenadah, Adel M.
    Asif, Muhammad
    Alqahtani, Mohammed H.
    Iqbal, Zafar
    Shaik, Munvar M.
    Gan, Siew H.
    Kamal, Mohammad A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (03) : 533 - 542
  • [6] Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications
    Tumminia, Andrea
    Vinciguerra, Federica
    Parisi, Miriam
    Frittitta, Lucia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [7] Iron, type 2 diabetes mellitus, and Alzheimer’s disease
    Luca Mascitelli
    Francesca Pezzetta
    Mark R. Goldstein
    Cellular and Molecular Life Sciences, 2009, 66 : 2943 - 2943
  • [8] Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease
    Carlsson, Cynthia M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (03) : 711 - 722
  • [9] Iron, type 2 diabetes mellitus, and Alzheimer's disease
    Mascitelli, Luca
    Pezzetta, Francesca
    Goldstein, Mark R.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (17) : 2943 - 2943
  • [10] Type 3 Diabetes Mellitus: A Link Between Alzheimer's Disease and Type 2 Diabetes Mellitus
    Nisar, Omar
    Pervez, Hira
    Mandalia, Bilvesh
    Waqas, Muhammad
    Sra, Harmandeep Kaur
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
12345